Description and Prediction of the Development of Metabolic Syndrome: A Longitudinal Analysis Using a Markov Model Approach

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Hwang, Lee Ching ^a,b   Bai, Chyi Huey ^c   You, San Lin ^d   Sun, Chien An ^e   Chen, Chien Jen ^d  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b MACKAY MEDICAL COLLEGE   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d GENOMICS RESEARCH CENTER   (Taiwan)

^e FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; LONGITUDINAL STUDY; MALE; METABOLIC SYNDROME X; ONSET AGE; PROBABILITY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SIMULATION; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; COMPUTER SIMULATION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MARKOV CHAINS; METABOLIC SYNDROME X; MIDDLE AGED; MODELS, BIOLOGICAL; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 84879262736     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067436     Document Type: Article

References (30)

1. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB, (2005) Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112: 3066-3072.
2. Prabhakaran D, Anand SS, (2004) The metabolic syndrome: an emerging risk state for cardiovascular disease. Vasc Med 9: 55-68.
3. Santos AC, Severo M, Barros H, (2010) Incidence and risk factors for the metabolic syndrome in an urban South European population. Prev Med 50: 99-105.
4. Wilsgaard T, Jacobsen BK, (2007) Lifestyle factors and incident metabolic syndrome. The Tromso Study 1979-2001. Diabetes Res Clin Pract 78: 217-224.
5. Kim BJ, Kim BS, Kang JH, (2012) Alcohol consumption and incidence of metabolic syndrome in korean men. A 3-year follow-up study. Circ J 76: 2363-2371.
6. Han TS, Williams K, Sattar N, Hunt KJ, Lean ME, et al. (2002) Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study. Obes Res 10: 923-931.
7. Haring R, Rosvall M, Volker U, Volzke H, Kroemer H, et al. (2012) A network-based approach to visualize prevalence and progression of metabolic syndrome components. PLoS One 7: e39461.
8. Silverstein MD, Albert DA, Hadler NM, Ropes MW, (1988) Prognosis in SLE: comparison of Markov model to life table analysis. J Clin Epidemiol 41: 623-633.
9. Andersen PK, Keiding N, (2002) Multi-state models for event history analysis. Stat Methods Med Res 11: 91-115.
10. Beck JR, (1988) Markov models of natural history. J Clin Epidemiol 41: 619-621.
11. Sonnenberg FA, Beck JR, (1993) Markov models in medical decision making: a practical guide. Med Decis Making 13: 322-338.
12. Craig BA, Fryback DG, Klein R, Klein BE, (1999) A Bayesian approach to modelling the natural history of a chronic condition from observations with intervention. Stat Med 18: 1355-1371.
13. Silverstein MD, Loftus EV, Sandborn WJ, Tremaine WJ, Feagan BG, et al. (1999) Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohort. Gastroenterology 117: 49-57.
14. Hwang LC, Bai CH, Chen CJ, (2006) Prevalence of obesity and metabolic syndrome in Taiwan. J Formos Med Assoc 105: 626-635.
15. Yang T, Chu CH, Bai CH, You SL, Chou YC, et al. (2012) Uric acid level as a risk marker for metabolic syndrome: a Chinese cohort study. Atherosclerosis 220: 525-531.
16. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, et al. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120: 1640-1645.
17. Macchia A, Levantesi G, Borrelli G, Franzosi MG, Maggioni AP, et al. (2006) A clinically practicable diagnostic score for metabolic syndrome improves its predictivity of diabetes mellitus: the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI)-Prevenzione scoring. Am Heart J 151: 754.e7-754.e17.
18. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, et al. (2010) The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 56: 1113-1132.
19. Tenenbaum A, Fisman EZ, (2011) "The metabolic syndrome. is dead": these reports are an exaggeration. Cardiovasc Diabetol 10: 11.
20. Despres JP, Lemieux I, (2006) Abdominal obesity and metabolic syndrome. Nature 444: 881-887.
21. Eckel RH, Alberti KG, Grundy SM, Zimmet PZ, (2010) The metabolic syndrome. Lancet 375: 181-183.
22. Cameron AJ, Boyko EJ, Sicree RA, Zimmet PZ, Soderberg S, et al. (2008) Central obesity as a precursor to the metabolic syndrome in the AusDiab study and Mauritius. Obesity (Silver Spring) 16: 2707-2716.
23. Regitz-Zagrosek V, Lehmkuhl E, Mahmoodzadeh S (2007) Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease. Gend Med 4 Suppl B: S162-177.
24. Spiegel BM, Targownik L, Dulai GS, Karsan HA, Gralnek IM, (2003) Endoscopic screening for esophageal varices in cirrhosis: Is it ever cost effective? Hepatology 37: 366-377.
25. Sonnenberg A, Naugler WE, (2010) Models of influence in chronic liver disease. Liver Int 30: 718-724.
26. Veenstra DL, Spackman DE, Di Bisceglie A, Kowdley KV, Gish RG, (2008) Evaluating anti-viral drug selection and treatment duration in HBeAg-negative chronic hepatitis B: a cost-effectiveness analysis. Aliment Pharmacol Ther 27: 1240-1252.
27. Sweeting MJ, Farewell VT, De Angelis D, (2010) Multi-state Markov models for disease progression in the presence of informative examination times: an application to hepatitis C. Stat Med. 29: 1161-1174.
28. Denton BT, Kurt M, Shah ND, Bryant SC, Smith SA, (2009) Optimizing the start time of statin therapy for patients with diabetes. Med Decis Making 29: 351-367.
29. Grassi A, Gaetano L, Pacini G, Kautzky-Willer A, Tura A, (2010) A Markov chain probability model of glucose tolerance in post gestational diabetes follow up study. Stud Health Technol Inform 160: 1155-1159.
30. Rigopoulou EI, Dalekos GN, (2010) Can mathematical models be useful in clinical hepatology? Liver Int 30: 637-638.